BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18756967)

  • 21. Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma.
    Celen O; Yildirim E; Ozen N; Sonmez C
    Neoplasma; 2006; 53(4):347-51. PubMed ID: 16830065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response.
    Lau GI; Loo WT; Chow LW
    Biomed Pharmacother; 2007 Oct; 61(9):562-5. PubMed ID: 17913448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study on the relationship between breast cancer molecular classification and prognosis].
    Chen XS; Ma CD; Chen CM
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1400-3. PubMed ID: 19094512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological characteristics and prognosis of patients with breast cancer over 65 years of age].
    Gao JD; Zhang BN; Wang X; Wang J; Bi XF
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):83-6. PubMed ID: 19489267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of medullary carcinoma of the breast].
    Li XX; Wang SM; Lai YH; Li SQ
    Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1516-8. PubMed ID: 16412287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
    Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
    J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
    Penault-Llorca F; Abrial C; Raoelfils I; Chollet P; Cayre A; Mouret-Reynier MA; Thivat E; Mishellany F; Gimbergues P; Durando X
    Oncologist; 2008 Dec; 13(12):1235-45. PubMed ID: 19091781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary metastases of breast cancer. When is resection indicated?
    Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.
    Wang S; Yang H; Tong F; Zhang J; Yang D; Liu H; Cao Y; Liu P; Zhou P; Cheng L; Liu M; Guo J
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):255-8. PubMed ID: 19223741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
    Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL
    Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].
    Liu CP; Shi L; Li Z
    Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1394-6. PubMed ID: 19094510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.